Mirum Pharmaceuticals, Inc.
MIRM
Jodie situation report
Mirum Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.
- MIRM's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MIRM's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind MIRM
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TAKTakeda Pharmaceutical Company LimitedpartnerFeb 25, 2026 ▾
“License, Finance, Royalty Agreements and Asset Purchases Assignment and License Agreement with Shire International GmbH (Takeda) In November 2018, we entered into an assignment and license agreement (“Shire License Agreement”) with Shire International GmbH (“…”
TAKTakeda Pharmaceutical Company LimitedcustomerFeb 25, 2026 ▾
“We expect that total product sales of our approved medicines will continue to increase on an annual basis; however, due to large periodic orders from Takeda and our distributors, our product revenue may experience quarterly fluctuations.”
Depended on by
TVTXTravere Therapeutics, Inc.partnerFeb 19, 2026 ▾
“Sale of Bile Acid Product Portfolio In July 2023, we entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Mirum Pharmaceuticals, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MIRM is currently a Early Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.